Literature DB >> 25305272

Projected age- and sex-specific prevalence of cardiovascular diseases in Western Australian adults from 2005-2045.

Danja Sarink1, Lee Nedkoff2, Tom Briffa2, Jonathan E Shaw3, Dianna J Magliano3, Christopher Stevenson4, Haider Mannan5, Matthew Knuiman2, Anna Peeters3.   

Abstract

BACKGROUND: For decades, the incidence and mortality of cardiovascular diseases (CVDs) have declined. More recently, we have seen a halting in these declines, especially at younger ages. It is difficult to predict how these changing trends will impact CVD prevalence. We aimed to predict future prevalence of CVDs in Western Australian adults from 2005-2045 based on current incidence and mortality probabilities, population growth and ageing. METHODS AND
RESULTS: Multi-state life table models were developed using 2005-2009 age- and sex-specific incidence and mortality probabilities from the Western Australian Data Linkage System. Prevalence of CVD, coronary heart disease (CHD) and stroke was projected until 2045. Life expectancy and lifetime risk were estimated. We estimate that compared to 2005-2009, we will see 37,235 (CVD), 23,129 (CHD) and 9806 (stroke) more incident cases in 2040-2044. The prevalence of total CVD is predicted to increase from 8.4% in men and 5.1% in women in 2005 to 12.7% and 7.9% respectively in 2045. This seems to be mainly due to population growth and ageing, with some effect of changing incidence and mortality. In Western Australia this represents an additional 106,949 adults living with CVD, of which 65,951 with CHD and 10,928 with stroke, in 2045 compared to 2005.
CONCLUSIONS: Assuming no major changes in prevention and treatment of CVD, the prevalence will likely increase, with consequent increases in health care need and cost. These findings need to be confirmed by studies in which prevalence is consistently and empirically measured and monitored over time. © The European Society of Cardiology 2014.

Entities:  

Keywords:  Cardiovascular diseases; coronary disease; epidemiology; stroke; temporal trends

Mesh:

Year:  2014        PMID: 25305272     DOI: 10.1177/2047487314554865

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  6 in total

1.  The Association of Vitamin D Status with Dyslipidaemia and Biomarkers of Endothelial Cell Activation in Older Australians.

Authors:  Ali M Alyami; Virginie Lam; Mario J Soares; Yun Zhao; Jillian L Sherriff; John C Mamo; Anthony P James; Fiona Coombes
Journal:  Nutrients       Date:  2016-07-28       Impact factor: 5.717

2.  Long-term trends in the prevalence of patients hospitalized with ischemic stroke from 1995 to 2010 in Sweden.

Authors:  Kok Wai Giang; Zacharias Mandalenakis; Susanne Nielsen; Lena Björck; Georgios Lappas; Martin Adiels; Christina Jern; Annika Rosengren
Journal:  PLoS One       Date:  2017-06-16       Impact factor: 3.240

3.  Designing a community participation management model to control the epidemic of heart coronary artery diseases for Tehran province.

Authors:  Vida Sadeghzadeh; Katayoun Jahangiri; Mahmood Mahmoodi Majdabadi Farahani; Mahmonir Mohammadi
Journal:  J Res Med Sci       Date:  2019-11-27       Impact factor: 1.852

Review 4.  Identification of Remarkable Dimensions in Management and Evaluation of Non-Communicable Disease Programmes: A systematic review and meta-synthesis.

Authors:  Leila Vali; Fatemeh Ataollahi; Mohammadreza Amiresmaili; Nouzar Nakhaee
Journal:  Sultan Qaboos Univ Med J       Date:  2021-08-29

5.  Complexity in disease management: A linked data analysis of multimorbidity in Aboriginal and non-Aboriginal patients hospitalised with atherothrombotic disease in Western Australia.

Authors:  Mohammad Akhtar Hussain; Judith M Katzenellenbogen; Frank M Sanfilippo; Kevin Murray; Sandra C Thompson
Journal:  PLoS One       Date:  2018-08-14       Impact factor: 3.240

6.  Hypertension prevalence in patients attending tertiary pain management services, a registry-based Australian cohort study.

Authors:  Melita J Giummarra; Hilarie Tardif; Megan Blanchard; Andrew Tonkin; Carolyn A Arnold
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.